Back to News
Market Impact: 0.2
Barclays Initiates Coverage of DexCom with Overweight Rating
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
On October 7, 2026, Barclays initiated coverage of DexCom with an Overweight recommendation, after maintaining an Underweight rating on May 18, 2026. The report provides no price target, rationale, or share-price reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
DXCM0.50
More News
- Susquehanna raises Marvell stock price target on data center growth
- Cantor Fitzgerald lowers Arthur J. Gallagher price target on EPS cuts
- W P Carey stock hits 52-week low at 63.08 USD
- European bank shares fall as bond yields surge, spreads widen
- Exclusive: Meet the 38-year-old founder who left Wall Street for love and created an AI insurance unicorn a decade later
- Existential threats join bubble fears as AI mood sobers at Singapore forums